Journal of Cervical Cancer invites submissions that advance cervical cancer prevention, early detection, and clinical care. We welcome original research, reviews, and translational studies that connect discovery science with measurable patient and population impact.

We prioritize rigor, transparency, and clinical relevance, especially research that improves screening uptake, HPV vaccine impact, and equitable outcomes.

The journal welcomes multidisciplinary contributions across gynecologic oncology, virology, diagnostics, and public health. Key topics include:

We also consider concise reports, protocol papers, and implementation studies when they deliver clear impact and reproducibility.

Submissions should include clearly defined endpoints, transparent statistical analysis, and justified sample sizes or power calculations. Where appropriate, share protocols and include trial or registry identifiers.

For clinical and observational work, provide patient selection criteria, consent procedures, and ethics approvals. For laboratory studies, describe assay validation and reproducibility checks.

We encourage authors to connect findings to actionable clinical practice or prevention strategy. This includes improvements in screening pathways, vaccine coverage, or treatment outcomes.

Submissions with strong implementation perspectives and equity focused outcomes are especially encouraged.

Choose the submission path that best fits your workflow. Both routes receive the same editorial review and production quality.

We welcome work that links HPV vaccination coverage, screening intervals, and follow up adherence with measurable reductions in incidence or mortality. Studies that integrate clinical pathways with community engagement and policy evaluation are especially valued.

Translational submissions should articulate how laboratory findings move toward diagnostics or therapeutics that improve early detection, staging, or treatment selection. Clear mechanistic insights and validation data strengthen impact.

Implementation science and health systems research that address access gaps, workforce training, and rural or low resource settings are strongly encouraged. Please describe scalability and sustainability considerations.

Manuscripts reporting AI assisted screening, imaging, or triage tools should include transparency on data sources, model validation, and bias assessment. Clinical utility and workflow integration should be addressed.

We encourage longitudinal cohorts that capture survivorship outcomes, recurrence patterns, and quality of life metrics. Patient reported outcomes can illuminate care improvements beyond standard clinical endpoints.

Collaborative, multi center studies are welcomed when they demonstrate harmonized protocols, data governance, and consistent outcome measurement across sites.

If your study includes policy analysis or economic evaluation, describe assumptions, sensitivity analyses, and the implications for cervical cancer control programs.

Cervical cancer research benefits from clear reporting of population characteristics, including age distribution, screening history, and vaccination status. This context helps readers interpret generalizability and informs policy decisions.

When describing interventions, explain how they align with clinical guidelines or public health recommendations. Contextualizing findings supports translation into care pathways.

Transparent reporting of funding sources and resource constraints helps readers assess feasibility in different settings. This is critical for global health adoption.

Where possible, include discussion of equity impacts and strategies to reduce disparities in screening or treatment access.

High quality visual summaries and clear tables improve uptake by clinicians and program managers. Provide succinct interpretations for key outputs.

Consider including patient engagement or community involvement approaches when they inform program design or trial recruitment.

Explain how results compare with prior evidence and identify remaining knowledge gaps for future cervical cancer research.

Journal of Cervical Cancer is dedicated to advancing cervical cancer prevention, diagnosis, and treatment through transparent publishing.

Our editorial office supports authors, reviewers, and readers with clear guidance and responsive communication. Contact [email protected] for scope or workflow questions.